Seven Starling, a virtual provider of women’s behavioral health services, has announced the successful closing of its $10.9 million Series A funding round. The oversubscribed investment round was led by RH Capital, with participation from existing investors Pear VC, Expa, Magnify Ventures, Emerson Collective, and Inflect Health, as well as new investors including Zeal Capital Partners, Ulu Ventures, Fiore Ventures, the March of Dimes, Rogue Venture Partners, Graham & Walker, and Wisdom Ventures. This funding will be instrumental in expanding access to specialized women’s mental healthcare, focusing on critical periods such as infertility, miscarriage and loss, pregnancy, postpartum, and parenthood.
“We are thrilled to have successfully raised this round of funding, which will allow us to expand our reach and help more women who need support during critical life transitions,” says Tina Beilinson Keshani, co-founder and CEO of Seven Starling. “This investment is a testament to the demand for a dedicated women’s mental health solution and our commitment to providing accessible, high-quality care. With the new funding, we will continue to successfully reduce the stigma around women’s mental health and ensure that every woman has access to the care she needs, when she needs it.”
Seven Starling’s primary focus is on maternal mental health. Statistics show that 94% of women do not seek help for perinatal mood and anxiety disorders due to barriers such as a shortage of therapists, limited in-network coverage, and high stigma surrounding these conditions. These disorders affect one in five women during the motherhood journey, yet only 20% are screened for mental health issues, and 75% of those who need treatment do not receive it. Seven Starling addresses these challenges by providing services that are easily accessible through extensive in-network coverage, an integrated group therapy model, and partnerships with referring providers to streamline the process for patients.
“We are proud to partner with Seven Starling in this new chapter to expand access to maternal mental healthcare, an area of significant need,” says Alice Zheng, MD, Principal at RH Capital. “We are excited by the comprehensive and scalable offerings, including group therapy to expand access. As a recent mom of two myself, I have been shocked by the lack of perinatal mental health support available relative to need and am thankful to see Seven Starling filling that gap.”
“Seven Starling is addressing a huge problem not just around motherhood but the entire female lifespace from adolescence to menopause,” says Mar Hershenson, Founder of Pear VC. “Women are nearly twice as likely as men to be diagnosed with depression or an anxiety disorder in their lifetime, but lack a tailored solution designed to meet their unique needs. Pear has partnered with Seven Starling since day one and we are excited to double down on them.”
Seven Starling’s unique clinical model, which includes specialized individual and group therapy, medication management, care coordination, and in-app content and exercises, drives superior clinical outcomes. Over 90% of patients report a clinically significant improvement in their symptoms upon completing the program. The company is a trusted resource for over 1,000 OBGYNs at private practices and hospitals across the country, with 90% of Seven Starling patients referred by their doctor. This approach helps address the $14 billion in additional healthcare costs associated with untreated maternal mental health conditions.
Expanding access to care is central to Seven Starling’s mission. The company partners with most major commercial health plans, including Anthem, Aetna, Cigna, United Healthcare, Kaiser Permanente, and Blue Cross Blue Shield. Over 85% of Seven Starling patients use their in-network insurance to pay for services, with typical copays ranging between $0-$30 per appointment. In its next phase, Seven Starling is preparing to accept Medicaid, furthering its commitment to making its services accessible to all women across the US.
“Mental health conditions, such as depression and anxiety, are among the most common complications for moms during pregnancy and the postpartum period,” said Kelly Ernst, March of Dimes SVP, Chief Impact Officer. “Many do not receive treatment they desperately need, which can lead to long-lasting clinical, social, and economic consequences. When these conditions are effectively treated and managed, everyone benefits. We’re proud to be investors in Seven Starling and look forward to seeing how their innovative and comprehensive approach improves the mental healthcare needs of women across the country.”
The capital raised from this round will be used to support continued national expansion, partner with Medicaid plans, and develop innovative technology to further integrate with healthcare partners. In addition to the funding, Zheng and Hershenson are joining Seven Starling’s board of directors, bringing extensive experience and insights to guide the company’s future strategies and expansion efforts.
